Farber, US
Aaron M. Farber, Tucson, AZ US
Patent application number | Description | Published |
---|---|---|
20140301535 | Gamma Ray Imaging Systems And Methods - A system for imaging a gamma source includes a pixelated Compton scattering layer, for Compton scattering of gamma photons emitted by the gamma source, and a non-pixelated full-energy detector for detecting at least a portion of Compton scattered gamma photons geometrically encoded by a coded aperture positioned between the pixelated Compton scattering layer and the full-energy detector at a distance from the pixelated Compton scattering layer. A method for imaging a gamma source includes (a) detecting coincidence events, each including Compton scattering in a pixelated Compton scattering layer, and transmission to a non-pixelated full-energy detector of a Compton scattered gamma photon transmitted through a coded aperture located at a distance from the pixelated Compton scattering layer, and (b) determining an image of the gamma source from the detection of the coincidence events. | 10-09-2014 |
Adam Lawrence Farber, Woodmere, NY US
Patent application number | Description | Published |
---|---|---|
20140074265 | SYSTEM AND METHOD FOR MONITORING THE USE OF AN EXERCISE APPARATUS - A smart phone or other portable device ( | 03-13-2014 |
Ben Farber, St. Petersburg, FL US
Patent application number | Description | Published |
---|---|---|
20110061459 | Method and Apparatus for Enhancing Measurement Accuracy for Beverage Preparations - A measuring device capable of enhancing accuracy of measurements for beverage preparations is disclosed. The measuring device includes a container having an opening. The opening is configured to allow a stream of liquid substance such as milk to enter. The container has a bottom and a side wall, wherein the side wall elevates from the bottom to the opening. The container is capable of retaining the stream of liquid substance. The side wall further includes markers, wherein each marker indicates a measurement of an Ingredient in accordance with the size of the beverage. | 03-17-2011 |
Bernard Farber, Memphis, TN US
Patent application number | Description | Published |
---|---|---|
20130137556 | SHIFTING CENTER-OF-BALANCE WEIGHTS - A series of weights in various sizes and configurations, where a fluid, including but not limited to water, moves and shifts inside the hollow body or bodies of the weight, thereby providing a shifting center-of-gravity to the device during use. This shifting requires greater effort from the user to maintain stability, and results in faster and greater muscular development over a standard set of weights with a fixed center of gravity. The body may comprise any desired shape or form, such as an oval, rectangle, square, or circle, and may have rounded corners or ends in order to promote flow of the fluid or water inside the body. The body also may comprise one or more connectors extending between body parts. One or more handles may be affixed to the body. | 05-30-2013 |
Boris Farber, Solon, OH US
Patent application number | Description | Published |
---|---|---|
20090078587 | Method of Sensor Conditioning for Improving Signal Output Stability for Mixed Gas Measurements - A method of sensor conditioning is proposed for improving signal output stability and differentiation between responses to different gases such as exhaust from combustion processes. DC (or saw tooth) voltage pulses of opposite polarity and equivalent amplitude are applied between sensor electrodes. Pulses are separated by pauses, when charging power supply is disconnected from the sensor and sensor discharge is recorded. Useful information regarding concentration of analyzed gases can be extracted from two measurement methods: | 03-26-2009 |
Boris S. Farber, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20110046888 | METHOD OF DIAGNOSING TUMOR DISORDERS IN HUMANS - The invention is used for the diagnosis of human tumoral diseases. The diagnosis method consists of preparing films from patient arterial and venous blood, processing said films using a conventional method such as fixing or dyeing, measuring the surface areas of the arterial and venous blood lymphocyte nuclei and comparing said surface areas to corresponding cell surface areas of different lymphocyte groups, plotting regression lines for the arterial and venous blood according to the values thus obtained, determining the percentage thereof for each lymphocyte group, plotting the influence curve thereof in the form of a function of the diameter of corresponding lymphocyte groups, introducing weight factors whose quantity increases along the lymphocyte diameter decrease, multiplying said factors by the lymphocyte percentage, and plotting the sums' correspondence for the arterial and venous blood in the form of the function of the difference therebetween. The diagnosis, location of the tumor, and degree of advancement of the oncological process are jointly determined according to the intersection and correlation of the regression lines and according to characteristic pictures and areas of the curves obtained. | 02-24-2011 |
20120129152 | Diagnostic method for the prediction of the development of and control over the effectiveness of treatment of cardiovascular illnesses - A diagnostic method for the prediction of the development and control of the effectiveness of the treatment of cardiovascular diseases, in which patient tissue samples are taken, microassay are prepared, specific antiviral immunoglobulins are processed, the number of cells infected by two or more viruses before the beginning of treatment are determined, and the dynamic of the change in the number of infected cells and their interrelationships are established: when the number of cells infected by cytomegalovirus and any other viruses decreases by more than 50±10% in patients without symptoms of cardiovascular pathology, a diagnostic conclusion is high danger of the development of atherosclerosis; if the number of cells infected by cytomegalovirus and any other viruses exceeds 50±10% in patients with demonstrated clinical signs of cardiovascular system pathology, a diagnostic conclusion is drawn of the danger of the development of complications such as arrhythmia, thrombolytic embolism. | 05-24-2012 |
20120129153 | Diagnostic method for the prediction of the development and control of the effectiveness of the treatment of oncological illnesses - A diagnostic method, in which patient tissue samples are taken, microassay are prepared, specific anti-viral immunoglobulins are processed, the number of cells infected by two or more viruses before the beginning of treatment are determined, and the dynamic of the change in the number of infected cells and their interrelationships are established: if the number of blood cells infected by any two or more viruses exceeds 50±10% in patients without signs of oncological pathology, a diagnostic conclusion is drawn of a high danger of oncological illness in connection with immune system ineffectiveness; if the number of cells infected by any two or more viruses exceeds 50±10% in patients with diagnosed oncological illnesses, a diagnostic conclusion of the cancer tumor's low sensitivity to chemotherapy and the perspective of quick tumor metastasis is drawn. | 05-24-2012 |
20120129195 | Method of quick laboratory diagnosis if illnesses based on the discovery of specific proteins and equipment for its implementation - A method of quick laboratory diagnosis of diseases, based on the discovery of specific protein targets characteristic to the disease in the reaction of their specific interaction with other protein reagents, distinct in that specific protein targets for the given disease are hydrolyzed with proteolytic enzymes and then the chemical structure of the oligopeptide formula created is modified in such a way that its charge is changed to the opposite. This method of quick laboratory diagnosis of illnesses based on the discovery of specific proteins, and the equipment for its implementation, may be applied for the discovery of viral and microbial antigens in various human biological fluids. The method may also be used for the detection of new and little-studied infectious diseases in connection with the ease of diagnostic preparation. | 05-24-2012 |
20120129760 | Modified peptides with antiviral properties and methods for obtaining them - This invention may be used in human and veterinary medicine for the creation of a drug that is effective perorally in the treatment of many viral infections, such as influenza, herpes, and cytomegalovirus. | 05-24-2012 |
20120129787 | Modified oligopeptides with anticancer properties and methods of obtaining them - This invention may be used in human and veterinary medicine for the creation of a drug that is effective perorally in the treatment of oncological illnesses. | 05-24-2012 |
20120130060 | Modified antisense oligopeptides with anticancer properties and method of obtaining them - This invention may be used in human and veterinary medicine for the creation of a drug that is effective in the treatment of oncological illnesses in animals and humans. | 05-24-2012 |
20120130699 | Method of molecular design and synthesis of therapeutic and preventive drugs - Industrial Application: This invention may be used in human and veterinary medicine for the design (creation and synthesis) of therapeutic and preventive drugs that are effective for the treatment of oncological and viral human and animal illnesses and for the design of new medicines. | 05-24-2012 |
20120195856 | Method of treating patients with cardiovascular illness - This invention may be used in human and veterinary medicine in combination with traditional methods of treatment of cardiovascular illnesses for the purpose of increasing their effectiveness. | 08-02-2012 |
20120195911 | Method of treatment of cancer patients - This invention may be used in human and veterinary medicine in combination with traditional methods of treatment of oncological illnesses for the purpose of increasing their effectiveness. | 08-02-2012 |
20120195925 | Vaccines with increased immunogenicity and methods for obtaining them - Vaccines with increased immunogenicity, distinct in that in the capacity of a specific immunogenic component, whole vaccine antigens or vaccine antigens that have been cut into oligomer fragments are used; the mixture (assembly) of oligomer fragments or whole antigen obtained is modified by changing its molecular charge to the opposite. | 08-02-2012 |
20120195945 | Cosmetological and pharmaceutical formulae for the rejuvenation and restoration of skin, including after surgical procedures - This invention is related to pharmacology and cosmetology and may be used in the capacity of a medicinal and cosmetic substance for skin anti-aging, scar reduction, treatment of post-operative peritoneal commissures, increasing the speed of post-operative tissue regeneration, and for the liquidation of cellulite. | 08-02-2012 |
20120196801 | Wound-healing, anti-ambustial, regenerating, and anti-viral pharmaceutical formula for local administration - The main active ingredients of the formula are papaverin, bendazol, and insulin. The drug may be produced in soft, liquid medicinal form or as an aerosol. | 08-02-2012 |
20120197003 | Modified oligopeptides for the treatment of pancreatitis, stomach ulcers, and other hyperenzymemias based on enzyme peptide inhibitors and methods for obtaining them - Modified oligopeptides for the treatment of pancreatitis, stomach ulcers, and other hyperenzymemias based on an enzyme peptide inhibitor where in the capacity of the main active ingredient, a mixture (assembly) of chemically modified oligopeptides are used that are products of autological hydrolysis of the same proteolytic enzymes of trypsin, chymotrypsin, and papain, with changes of their molecular charges to the opposite through acylation with succinic anhydride and alkylation by monochloracetic acid. | 08-02-2012 |
20130288230 | Method for identification of a natural biopolymer - The invention presents a method of identifying natural biopolymer—a protein, DNA, RNA in biological fluids and environmental objects, which is based only on the structure of the biopolymer and does not require pathogen genome sequencing, or animals vaccination by biopolymer-antigen. For this purpose the biopolymer itself is taken—a protein, DNA, or RNA, that is fragmented with enzyme to oligomer fragments—a mixture of oligopeptides, oligonucleotides DNA mixture, mixture of RNA oligonucleotides, without dividing the mixture into individual components, then carboxylation of structure in oligomer components is performed by acylation or alkylation. | 10-31-2013 |
20140220556 | Method of Design and Synthesis of a New Drug - A method of design and synthesis of a new drug. This invention may be used in human and veterinary medicine for the design of new drugs that are effective in the treatment of oncological and viral human and animal illnesses and for the design of new medicines. In the method a biopolymer target for the drug action is selected; then the quantity of nitrogen-containing positively charged groups available for modification is calculated. Biopolymer target may be cut into oligomer fragments. Some of calculated nitrogen-containing positively charged groups are substituted with negatively charged groups by combinatorial modification. The obtained supramolecular assemblies are used as drug for the biopolymer target. | 08-07-2014 |
20140309276 | Pharmaceutical Composition Comprising a Mixture of Carboxylated Oligonucleotides - The invention describes a pharmaceutical composition, comprising a mixture of carboxylated oligonucleotides, obtained by hydrolysis of natural polynucleotides, that results in oligonucleotide mixture, and carboxylation of purine nucleotide bases in the oligonucleotide mixture. The oligonucleotide mixture (DNA, RNA, or a combination of the two) of plant, animal, or fungal origin is conducted through chemical or biochemical enzymatic procedures, and then, a chemical modification of the oligonucleotides is provided, with carboxylation of their purine nucleotide bases through alkylation with monochloroacetic acid, or acylation with succinic anhydride. The pharmaceutical composition may be used in humans and animals for cancer treatment, immunodeficiency, viral infection diseases, etc. | 10-16-2014 |
20150072929 | Pharmaceutical composition comprising a mixture of carboxylated oligopeptides - A pharmaceutical composition comprising a mixture of carboxylated oligopeptides, derived by hydrolysis of eukaryotic or prokaryotic cells and their subsequent partial carboxylation through acylation or alkylation of the amino acid and basic amino acid residues in the amino terminal structure of the oligopeptides. The resulting pharmaceutical composition can be used in production of medical drugs effective in the treatment of cancer, pancreatitis, viral infection, for the development of vaccines. | 03-12-2015 |
20150174208 | Cosmetic and pharmaceutical composition with modified olygopeptides in form of supramolecular assembly - The invention is a cosmetic and pharmaceutical liposomal composition which comprises a mixture of carboxylated oligopeptides derived from natural polypeptides; insulin; hyaluronidase and collagenase by their enzymatic hydrolysis; followed by a carboxylation of the free amino groups of lysine, histidine, and additional hydrolysis of terminal amino groups in the oligopeptides. Natural polypeptides may be hydrolyzed with a proteolytic enzyme to form a mixture of oligopeptides and succinylated them. Next, the resulting mixture was injected into the liposomes by classical methods to improve the intestinal absorption and bioavailability in the body, prolonging the action of the system. Such a system behaves as quasi-live and is capable of forming supramolecular complexes with the original proteins, such as insulin and acylated insulin oligopeptides, or insulin receptors on a cell and acylated insulin's oligopeptides. These cosmetic formulations may be used as prophylactic and therapeutic drugs in the prevention of infectious diseases as do vaccines in the treatment of cancer; pancreatitis and other diseases; rejuvenation of skin and body; and acceleration of wound healing. | 06-25-2015 |
Boris Y. Farber, Solon, OH US
Patent application number | Description | Published |
---|---|---|
20090036291 | GRINDING BEADS AND METHOD OF PRODUCING THE SAME - A ceramic consisting essentially of: | 02-05-2009 |
Charles R. Farber, Charlottesville, VA US
Patent application number | Description | Published |
---|---|---|
20150218556 | COMPOSITIONS AND METHODS FOR TREATING PERIPHERAL ARTERIAL DISEASE - The present application discloses roles for miR-93 in treating hypoxia and ischemia. Endothelial cells (HUVEC) and myocytes (C2C12) expressed miR-93 and up-regulated miR-93 in response to hypoxia and serum starvation. Over-expression of miR-93 in HUVECs promoted cell proliferation, prevented hypoxia-induced apoptosis, and enhanced endothelial cell tube formation. miR-93 knockdown in HUVECs resulted in increased hypoxia-induced apoptosis and decreased tube formation. Over-expression or knockdown of miR-93 in myocytes resulted in reduced or increased hypoxia-induced apoptosis, respectively. Down-regulation of miR-93 in C57BL/6 mice with antagomiR resulted in attenuated perfusion recovery (% non-ischemic leg at day-21: Scramble 85.22.9 vs. AntagomiR-93 67.96). Over-expression of miR-93 in BALB/C mice improved perfusion recovery (% non-ischemic leg at day 21: PremiR-93 757.5 vs. Scramble 59.62.5). The present invention encompasses the use of miR-93 and regulation of miR-93 to treat and prevent hypoxia, ischemia, and other injuries, diseases, disorders, and conditions associated with ischemia. | 08-06-2015 |
David Farber, Austin, TX US
Patent application number | Description | Published |
---|---|---|
20100164093 | HEAT DISSIPATION IN TEMPERATURE CRITICAL DEVICE AREAS OF SEMICONDUCTOR DEVICES BY HEAT PIPES CONNECTING TO THE SUBSTRATE BACKSIDE - By providing heat dissipation elements or heat pipes in temperature critical areas of a semiconductor device, enhanced performance, reliability and packing density may be achieved. The heat dissipation elements may be formed on the basis of standard manufacturing techniques and may be positioned in close proximity to individual transistor elements and/or may be used for shielding particular circuit portions. | 07-01-2010 |
David Farber, Plano, TX US
Patent application number | Description | Published |
---|---|---|
20140187009 | UNIFORM, DAMAGE FREE NITRIDE ETCH - An integrated circuit may be formed by forming a sacrificial silicon nitride feature. At least a portion of the sacrificial silicon nitride feature may be removed by placing the integrated circuit in a two-step oxidized layer etch tool and removing a surface layer of oxidized silicon from the sacrificial silicon nitride feature using a two-step etch process. The two-step etch process exposes the integrated circuits to reactants from a plasma source at a temperature less than 40° C. and subsequently heating the integrated circuit to 80° C. to 120° C. while in the two-step oxidized layer etch tool. While the integrated circuit is in the two-step oxidized layer etch tool, without exposing the integrated circuit to an ambient containing more than 1 torr of oxygen, at least a portion of the sacrificial silicon nitride feature is removed using fluorine-containing etch reagents, substantially free of ammonia. | 07-03-2014 |
20150187661 | DUAL LAYER HARDMASK FOR EMBEDDED EPI GROWTH - A process for forming an integrated circuit with an embedded epitaxially grown semiconductor using an epi blocking bilayer. The epi blocking bilayer comprised of a two different materials that may be etched selectively with respect to each other such as silicon nitride and silicon dioxide. | 07-02-2015 |
David Farber, Westminster, CO US
Patent application number | Description | Published |
---|---|---|
20120095865 | System And Method For Mobile Electronic Purchasing - A system and method for electronic purchasing via a mobile web-enabled communication device. A contacts list containing shipping addresses, and a payment file containing encrypted credit card information for one or more credit cards is stored on the mobile device. In response to a request for credit card and shipping information from a merchant website for an item to be purchased, a specific one of the credit cards and a specific one of the shipping addresses is selected from the contacts list and the payment file, respectively. The credit card data for the selected credit card is decrypted, and the decrypted credit card data and the selected shipping address are sent to the merchant website for order processing. | 04-19-2012 |
David G. Farber, Austin, TX US
Patent application number | Description | Published |
---|---|---|
20090286389 | METHOD OF OPTIMIZING SIDEWALL SPACER SIZE FOR SILICIDE PROXIMITY WITH IN-SITU CLEAN - A method that includes forming a gate of a semiconductor device on a substrate, and etching sidewall spacers on sides of the gate to provide a proximity value, where the proximity value is defined as a distance between the gate and an edge of a performance-enhancing region. The sidewall spacers are used to define the edge of the region during formation of the region in the substrate. The method also includes pre-cleaning the gate and the substrate in preparation for formation of the region, where the etching and the pre-cleaning are performed in a continuous vacuum. | 11-19-2009 |
20100102363 | AIR GAP SPACER FORMATION - Miniaturized complex transistor devices are formed with reduced leakage and reduced miller capacitance. Embodiments include transistors having reduced capacitance between the gate electrode and source/drain contact, as by utilizing a low-K dielectric constant sidewall spacer material. An embodiment includes forming a gate electrode on a semiconductor substrate, forming a sidewall spacer on the side surfaces of the gate electrode, forming source/drain regions by ion implantation, forming an interlayer dielectric over the gate electrode, sidewall spacers, and substrate, and forming a source/drain contact through the interlayer dielectric. The sidewall spacers and interlayer dielectric are then removed. A dielectric material, such as a low-K dielectric material, is then deposited in the gap between the gate electrode and the source/drain contact so that an air gap is formed, thereby reducing the parasitic “miller” capacitance. | 04-29-2010 |
20100296238 | HEAT MANAGEMENT USING POWER MANAGEMENT INFORMATION - A multi-core microprocessor provides an indication of the power management state of each of the cores on output terminals. Cooling of the cores is adjusted responsive to the indication of the power management state of the respective cores with additional cooling being provided to those cores in a more active state and less cooling provided to those cores in a less active state. | 11-25-2010 |
20120039041 | HEAT MANAGEMENT USING POWER MANAGEMENT INFORMATION - A multi-core microprocessor provides an indication of the power management state of each of the cores on output terminals. Cooling of the cores is adjusted responsive to the indication of the power management state of the respective cores with additional cooling being provided to those cores in a more active state and less cooling provided to those cores in a less active state. | 02-16-2012 |
David Gerald Farber, Austin, TX US
Patent application number | Description | Published |
---|---|---|
20090042399 | Method for Dry Develop of Trilayer Photoresist Patterns - A method of forming a feature on a multi-layer semiconductor is disclosed. A pattern feature is formed in an uppermost layer of the multi-layer semiconductor. The multilayer semiconductor is etched with a SO | 02-12-2009 |
David Gerald Farber, Wylie, TX US
Patent application number | Description | Published |
---|---|---|
20080268589 | SHALLOW TRENCH DIVOT CONTROL POST - The disclosure provides a method of manufacturing a semiconductor device. The method comprises forming a shallow trench isolation structure, including performing a wet etch process to remove a patterned pad oxide layer located on a semiconductor substrate. The wet etch thereby produces a divot on upper lateral edges of a insulator-filled trench in the semiconductor substrate. Forming the shallow trench isolation structure also includes forming a nitride post on a vertical wall of the divot. Forming the nitride post includes depositing a nitride layer on the insulator, and dry etching the nitride layer. The dry etch is selective towards the nitride located adjacent the vertical wall such that a portion of the nitride layer remains on the vertical wall subsequent to the dry etching. | 10-30-2008 |
David Gerald Farber, Plano, TX US
Patent application number | Description | Published |
---|---|---|
20120064686 | Lateral Uniformity in Silicon Recess Etch - A method of etching recesses into silicon prior to formation of embedded silicon alloy source/drain regions. The recess etch includes a plasma etch component, using an etch chemistry of a primary fluorine-based or chlorine-based etchant, in combination with a similar concentration of hydrogen bromide. The concentration of both the primary etchant and the hydrogen bromide is relatively low; a diluent of an inert gas or oxygen is added to the reactive species. Loading effects on the undercut of the recess etch are greatly reduced, resulting in reduced transistor performance variation. | 03-15-2012 |
20150044830 | HARD MASK FOR SOURCE/DRAIN EPITAXY CONTROL - An integrated circuit is formed to include a first polarity MOS transistor and a second, opposite, polarity MOS transistor. A hard mask of silicon-doped boron nitride (Si | 02-12-2015 |
David J. Farber, Pittsburgh, PA US
Patent application number | Description | Published |
---|---|---|
20090252310 | Dial Up Telephone Conferencing System Controlled by an Online Computer Network - In a telephone conferencing system, a digital communication network such as the Internet is used to establish and control the telephone connections between multiple conferees with the telephone network being the means of exchanging verbal information. Each conferee may have a computer connected to the digital network, and each has an independent telephone instrument connected to the public switched telephone network. An in-charge conferee utilizes his computer containing appropriate software to initiate the conference and to control the participation of the conferees. The in-charge conferee sends digital control signals to a switch interface controlling a telephone switch as a gateway to the telephone network using SS | 10-08-2009 |
20120140909 | DIAL UP TELEPHONE CONFERENCING SYSTEM CONTROLLED BY AN ONLINE COMPUTER NETWORK - In a telephone conferencing system, a digital communication network such as the Internet is used to establish and control the telephone connections between multiple conferees with the telephone network being the means of exchanging verbal information. Each conferee may have a computer connected to the digital network, and each has an independent telephone instrument connected to the public switched telephone network. An in-charge conferee utilizes his computer containing appropriate software to initiate the conference and to control the participation of the conferees. The in-charge conferee sends digital control signals to a switch interface controlling a telephone switch as a gateway to the telephone network using SS7 control signals. These SS7 control signals include the commands by which the conferee telephones are rung up, brought on line, or dropped from the conference. | 06-07-2012 |
Donald W. Farber, Towson, MD US
Patent application number | Description | Published |
---|---|---|
20110014855 | ADAPTER FOR ABRASIVE CUTTING WHEELS - An abrasive disc assembly for a tool having an externally threaded, motor-driven spindle. The assembly includes an abrasive disc having a central bore formed therethrough and a male portion having an internally-threaded hub portion and a flange portion. The outer dimension of the hub portion is sized to be received within the central bore and the internally-threaded hub portion is enmeshingly engagable with the externally threaded, motor-driven spindle. The assembly further comprises an articulating locking finger extending from the male portion and having a retaining surface. The articulating locking finger is deflectable between a locked position and a deflected position. Finally, the assembly includes a female portion having a central cavity and an engagement surface. The central cavity receives the hub portion of the male portion such that the retaining surface of the articulating locking finger engages the engagement surface thereby releasably coupling the male portion to the female portion and retaining the abrasive disc therebetween. | 01-20-2011 |
20120071073 | WEARABLE BACKING FOR AN ABRASIVE FLAP DISK - A structure for a backing plate of an abrasive disk is disclosed. The structure includes layers of abrasive resin interspersed with layers of reinforcing fiberglass. The layers are generally disk shaped and cover certain radial intervals of the entire backing plate between the inner diameter and the outer diameter. For example, a radial stress profile plotting the stress along a radial line from inner to outer diameter can be determined. The amount and radial positioning of reinforcing layers (e.g., reinforcing fiberglass) may then be determined. An appropriate amount of reinforcing layers may then be placed within the radial intervals that experience the highest stress. | 03-22-2012 |
20120083193 | UNIVERSAL ABRASIVE DISC - An abrasive disc adapted to mount on a surface of a sander, such as an orbital sander, having either five or eight dust extraction holes is provided. The abrasive disc includes a plurality of apertures arrangeable to at least partially overlap each of the five or eight dust extraction holes of the orbital sander. | 04-05-2012 |
Donna Farber, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20100331391 | ZAP-70 AS PREDICTOR AND MODULATOR OF EFFECTOR FUNCTION OF T CELLS - In this application is described a novel, multiparameter analysis of TCR-coupled signaling and function in resting and activated naive and memory CD4 T cells, revealing a biochemical basis for immunological recall. Results reveal a novel biochemical signature imparted to memory CD4 T cells enabling efficacious responses through increased ZAP-70 expression and reduced accumulation of downstream signaling events. | 12-30-2010 |
Elliott Farber, Apple Valley, MN US
Patent application number | Description | Published |
---|---|---|
20140121255 | Methods of Treating Psoriasis Using Allantoin - Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0.5% to about 15.0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis herpetiform, contact dermatitis, arthritis, gout, lupus erythematosus, acne, alopecia, carcinomas, psoriasis, rosacea, miliaria, skin infections, post-operative care of incisions, post-operative skin care following any variety of plastic surgery operations, skin care following radiation treatment, care of dry, cracked or aged skin and skin lines as well as other conditions affecting the skin and having an inflammatory component, symptoms thereof, or a combination thereof. Symptoms treated may include pain, inflammation, redness, itching, scarring, skin thickening, milia, or a combination thereof. | 05-01-2014 |
20140135372 | COMPOSITIONS AND METHODS OF TREATMENT OF INFLAMMATORY SKIN CONDITIONS USING ALLANTOIN - Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0.5% to about 15.0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis herpetiform, contact dermatitis, arthritis, gout, lupus erythematosus, acne, alopecia, carcinomas, psoriasis, rosacea, miliaria, skin infections, post-operative care of incisions, post-operative skin care following any variety of plastic surgery operations, skin care following radiation treatment, care of dry, cracked or aged skin and skin lines as well as other conditions affecting the skin and having an inflammatory component, symptoms thereof, or a combination thereof. Symptoms treated may include pain, inflammation, redness, itching, scarring, skin thickening, milia, or a combination thereof. | 05-15-2014 |
20140194482 | COMPOSITIONS AND METHODS OF TREATMENT OF INFLAMMATORY SKIN CONDITIONS USING ALLANTOIN - Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0.5% to about 15.0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis herpetiform, contact dermatitis, arthritis, gout, lupus erythematosus, acne, alopecia, carcinomas, psoriasis, rosacea, miliaria, skin infections, post-operative care of incisions, post-operative skin care following any variety of plastic surgery operations, skin care following radiation treatment, care of dry, cracked or aged skin and skin lines as well as other conditions affecting the skin and having an inflammatory component, symptoms thereof, or a combination thereof. Symptoms treated may include pain, inflammation, redness, itching, scarring, skin thickening, milia, or a combination thereof. | 07-10-2014 |
20140206732 | Compositions and Methods of Treatment of Inflammatory Skin Conditions Using Allantoin - Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0.5% to about 15.0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis herpetiform, contact dermatitis, arthritis, gout, lupus erythematosus, acne, alopecia, carcinomas, psoriasis, rosacea, miliaria, skin infections, post-operative care of incisions, post-operative skin care following any variety of plastic surgery operations, skin care following radiation treatment, care of dry, cracked or aged skin and skin lines as well as other conditions affecting the skin and having an inflammatory component, symptoms thereof, or a combination thereof. Symptoms treated may include pain, inflammation, redness, itching, scarring, skin thickening, milia, or a combination thereof. | 07-24-2014 |
20140288137 | COMPOSITIONS AND METHODS OF TREATMENT OF INFLAMMATORY SKIN CONDITIONS USING ALLANTOIN - Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0.5% to about 15.0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis herpetiform, contact dermatitis, arthritis, gout, lupus erythematosus, acne, alopecia, carcinomas, psoriasis, rosacea, miliaria, skin infections, post-operative care of incisions, post-operative skin care following any variety of plastic surgery operations, skin care following radiation treatment, care of dry, cracked or aged skin and skin lines as well as other conditions affecting the skin and having an inflammatory component, symptoms thereof, or a combination thereof. Symptoms treated may include pain, inflammation, redness, itching, scarring, skin thickening, milia, or a combination thereof. | 09-25-2014 |
Elliott Farber, North Mankato, MN US
Patent application number | Description | Published |
---|---|---|
20080269308 | ALLANTOIN-CONTAINING SKIN CREAM - An allantoin-containing skin cream composition can comprise allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water. The composition is in the form of an oil-in-water emulsion. The pH of the composition is in a range of from about 3.0 to about 6.0; preferably, the pH of the composition is from about 5.0 to about 6.0. The composition can further comprise an acidic anionic polymer. A preferred acidic anionic polymer is a carboxypolymethylene polymer. The composition can further comprise a carbohydrate polymer such as galactoarabinan, polygalactose or polyarabinose. The composition can additionally comprise other ingredients such as herbal extracts, an antioxidant component, an emollient component, a chelator, a solvent component, or a preservative component. The composition is useful as a skin protectant. | 10-30-2008 |
20090170919 | METHODS FOR TREATMENT OF INFLAMMATORY DISEASES - An improved method of treating skin diseases comprises applying to the skin of a patient suffering such a skin disease an allantoin-containing composition in a therapeutically effective quantity. The allantoin-containing composition is an oil-in-water emulsion that includes allantoin and an emulsifier system that includes at least one emulsifier that is either an anionic emulsifier or a nonionic emulsifier. The pH of the composition used in a method according to the present invention is from approximately 3.0 to approximately 6.0; a narrower pH range can be used, varying with each embodiment of the composition. | 07-02-2009 |
20110152335 | ALLANTOIN-CONTAINING SKIN CREAM - An allantoin-containing skin cream composition can comprise allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water. The pH of the composition is in a range of from about 3.0 to about 6.0; preferably, the pH of the composition is from about 5.0 to about 6.0. The composition can further comprise an acidic anionic polymer. A preferred acidic anionic polymer is a carboxypolymethylene polymer. The composition can further comprise a carbohydrate polymer such as galactoarabinan, polygalactose or polyarabinose. The composition can additionally comprise other ingredients such as herbal extracts, an antioxidant component, an emollient component, a chelator, a solvent component, or a preservative component. The composition is useful as a skin protectant. | 06-23-2011 |
20110165260 | ALLANTOIN-CONTAINING SKIN CREAM - An allantoin-containing skin cream composition can comprise allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water. The composition is in the form of an oil-in-water emulsion. The pH of the composition is in a range of from about 3.0 to about 6.0; preferably, the pH of the composition is from about 5.0 to about 6.0. The composition can further comprise an acidic anionic polymer. A preferred acidic anionic polymer is a carboxypolymethylene polymer. The composition can further comprise a carbohydrate polymer such as galactoarabinan, polygalactose or polyarabinose. The composition can additionally comprise other ingredients such as herbal extracts, an antioxidant component, an emollient component, a chelator, a solvent component, or a preservative component. The composition is useful as a skin protectant. | 07-07-2011 |
20120065238 | ALLANTOIN-CONTAINING SKIN CREAM - An allantoin-containing skin cream composition can comprise allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water. The composition is in the form of an oil-in-water emulsion. The pH of the composition is in a range of from about 3.0 to about 6.0; preferably, the pH of the composition is from about 5.0 to about 6.0. The composition can further comprise an acidic anionic polymer. A preferred acidic anionic polymer is a carboxypolymethylene polymer. The composition can further comprise a carbohydrate polymer such as galactoarabinan, polygalactose or polyarabinose. The composition can additionally comprise other ingredients such as herbal extracts, an antioxidant component, an emollient component, a chelator, a solvent component, or a preservative component. The composition is useful as a skin protectant. | 03-15-2012 |
20120165379 | ALLANTOIN-CONTAINING SKIN CREAM - An allantoin-containing skin cream composition can comprise allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water. The pH of the composition is in a range of from about 3.0 to about 6.0; preferably, the pH of the composition is from about 5.0 to about 6.0. The composition can further comprise an acidic anionic polymer. A preferred acidic anionic polymer is a carboxypolymethylene polymer. The composition can further comprise a carbohydrate polymer such as galactoarabinan, polygalactose or polyarabinose. The composition can additionally comprise other ingredients such as herbal extracts, an antioxidant component, an emollient component, a chelator, a solvent component, or a preservative component. The composition is useful as a skin protectant. | 06-28-2012 |
20130030030 | ALLANTOIN-CONTAINING SKIN CREAM - An allantoin-containing skin cream composition can comprise allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water. The composition is in the form of an oil-in-water emulsion. The pH of the composition is in a range of from about 3.0 to about 6.0; preferably, the pH of the composition is from about 5.0 to about 6.0. The composition can further comprise an acidic anionic polymer. A preferred acidic anionic polymer is a carboxypolymethylene polymer. The composition can further comprise a carbohydrate polymer such as galactoarabinan, polygalactose or polyarabinose. The composition can additionally comprise other ingredients such as herbal extracts, an antioxidant component, an emollient component, a chelator, a solvent component, or a preservative component. The composition is useful as a skin protectant. | 01-31-2013 |
20130345274 | ALLANTOIN-CONTAINING SKIN CREAM - An allantoin-containing skin cream composition can comprise allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water. The composition is in the form of an oil-in-water emulsion. The pH of the composition is in a range of from about 3.0 to about 6.0; preferably, the pH of the composition is from about 5.0 to about 6.0. The composition can further comprise an acidic anionic polymer. A preferred acidic anionic polymer is a carboxypolymethylene polymer. The composition can further comprise a carbohydrate polymer such as galactoarabinan, polygalactose or polyarabinose. The composition can additionally comprise other ingredients such as herbal extracts, an antioxidant component, an emollient component, a chelator, a solvent component, or a preservative component. The composition is useful as a skin protectant. | 12-26-2013 |
20140005242 | Allantoin-Containing Skin Cream | 01-02-2014 |
20140142151 | ALLANTOIN-CONTAINING SKIN CREAM - An allantoin-containing skin cream composition can comprise allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water. The composition is in the form of an oil-in-water emulsion. The pH of the composition is in a range of from about 3.0 to about 6.0; preferably, the pH of the composition is from about 5.0 to about 6.0. The composition can further comprise an acidic anionic polymer. A preferred acidic anionic polymer is a carboxypolymethylene polymer. The composition can further comprise a carbohydrate polymer such as galactoarabinan, polygalactose or polyarabinose. The composition can additionally comprise other ingredients such as herbal extracts, an antioxidant component, an emollient component, a chelator, a solvent component, or a preservative component. The composition is useful as a skin protectant. | 05-22-2014 |
Emanuel E. Farber, New York, NY US
Patent application number | Description | Published |
---|---|---|
20120293522 | Browser for Use in Navigating a Body of Information, with Particular Application to Browsing Information Represented by Audiovisual Data - A method for enabling a user to review a body of information that includes first and second segments from respective first and second information sources includes: storing second segment digital data representing the second segments; receiving an indication that the user has selected for display a particular first segment; identifying one or more of the second segments that are related to the particular first segment by comparing first segment digital data to the second segment digital data; and providing display digital data for display of one or more representations or portions of the identified second segments contemporaneously with display of the particular first segment. The display digital data enables the displayed representations or portions of the second segments to be selected by the user when displayed. | 11-22-2012 |
George Farber, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20090184595 | SYSTEM AND METHOD FOR MAGNETIC LEVITATION WITH TILTED ORIENTATION - A system and method for magnetic levitation with a tilted orientation. In one embodiment, a magnetic levitation base together with a magnetic levitation affecting element that is located to the side of the levitation base support the magnetic levitation of a spinning magnetic top in a tilted orientation. The tilt angle of the levitating magnetic top may be greater than the tilt angle of the levitation base. In one embodiment, the levitation affecting element may comprise one or more magnets similar to that of the levitation base. The mass of the top and the tilt of the levitation base that are required for magnetic levitation may be adjusted by adjusting the levitation affecting element (e.g. altering its position and/or the strength of its magnetic field.) The general direction of the tilt may be reversed by changing the magnetic north-south direction (e.g. turning over or reversing the electromagnetic current) of the levitation affecting element. | 07-23-2009 |
James Farber, Holland, MI US
Patent application number | Description | Published |
---|---|---|
20150371408 | Vehicle Informatin Display System and Methods - An apparatus for displaying information to an occupant of a vehicle including a display coupled to the vehicle, the display configured to display an image based on information stored in a frame buffer, and a control circuit coupled to the display, the control circuit configured to receive information related to the vehicle from a vehicle electronics system, wherein the control circuit is configured to display a digital instrument based on the information related to the vehicle by revealing a color gradient bitmap background using a bitmap mask and storing the result in the frame buffer, and wherein the bitmap mask is moved relative to the color gradient bitmap. | 12-24-2015 |
James Farber, Rumson, NJ US
Patent application number | Description | Published |
---|---|---|
20080240416 | Telephone with Enhanced Function Display and Selection Ability - A user interface, telephony device, and method for managing user control settings associated with a telephony device is described. The user interface displays a label array on a display device of the telephony device. The label array includes at least one row of labels, each representing a discrete function or feature associated with the telephony device. A button array is provided in the vicinity of the display device. The button array includes a corresponding row or rows of buttons, each button representing a discrete function or feature for the telephony device and corresponding to a label within the label array. One or more buttons in the button array are selectively illuminated to indicate a status of one or more functions or features associated with one or more labels in the label array. | 10-02-2008 |
20090232293 | METHOD FOR OPERATING A TELEPHONE SYSTEM WITH AT LEAST TWO TELEPHONY TERMINALS AND A TELEPHONY TERMINAL FOR CARRYING OUT THE METHOD - A method for operating a telephone system with at least two telephony terminals to where, in addition to voice data or user data, functional data is transmitted by means of special functions of the telephone system, such as forwarding or holding established call connections. It shall be possible in a simple way for the user to handle even a relatively large multitude of special functions. For this purpose, according to the invention, an action key of a first telephony terminal, provided for triggering special functions is assigned the respective special function to be triggered, depending on its own status or the status of a second telephony terminal within the same team. | 09-17-2009 |
Jason Farber, East Brunswick, NJ US
Jeffrey Farber, Delmar, NY US
Patent application number | Description | Published |
---|---|---|
20090078282 | Method and Apparatus for Cleaning Semiconductor Wafers Using Compressed and/or Pressurized Foams, Bubbles, and/or Liquids - An apparatus and method are disclosed in which a semiconductor substrate having a surface containing contaminants is cleaned or otherwise subjected to chemical treatment using a foam. The semiconductor wafer is supported either on a stiff support (or a layer of foam) and foam is provided on the opposite surface of the semiconductor wafer while the semiconductor wafer is supported. The foam contacting the semiconductor wafer is pressurized using a form to produce a jammed foam. Relative movement between the form and the semiconductor wafer. such as oscillation parallel and/or perpendicular to the top surface of the semiconductor wafer. is then induced while the jammed foam is in contact with the semiconductor wafer to remove the undesired contaminants and/or otherwise chemically treat the surface of the semiconductor wafer using the foam. | 03-26-2009 |
20090320884 | CONTROLS OF AMBIENT ENVIRONMENT DURING WAFER DRYING USING PROXIMITY HEAD - A method for processing a substrate is provided which includes generating a fluid meniscus to process the substrate and applying the fluid meniscus to a surface of the substrate. The method further includes reducing evaporation of fluids from a surface in the substrate processing environment. | 12-31-2009 |
20120017950 | METHOD AND APPARATUS FOR CLEANING A SUBSTRATE USING NON-NEWTONIAN FLUIDS - A method for cleaning a substrate is provided. In this method, a flow of non-Newtonian fluid is provided where at least a portion of the flow exhibits plug flow. To remove particles from a surface of the substrate, the surface of the substrate is placed in contact with the portion of the flow that exhibits plug flow such that the portion of the flow exhibiting plug flow moves over the surface of the substrate. Additional methods and apparatuses for cleaning a substrate also are described. | 01-26-2012 |
20120129344 | PROCESS AND APPARATUS FOR REMOVAL OF CONTAMINATING MATERIAL FROM SUBSTRATES - A process for removing contaminating metals from a substrate to improve electrical performance is provided. Polycationic metals are known to be particularly detrimental to the electrical properties of an insulator or semiconductor substrate. The process includes the exposure of the substrate to an aqueous solution of at least one compound of the formula: (I) where n in each occurrence is independently an integer value between 0 and 6, and X is independently in each occurrence H, NR | 05-24-2012 |
20140158167 | METHOD AND APPARATUS FOR CLEANING A SUBSTRATE USING NON-NEWTONIAN FLUIDS - A method for cleaning a substrate is provided. In this method, a flow of non-Newtonian fluid is provided where at least a portion of the flow exhibits plug flow. To remove particles from a surface of the substrate, the surface of the substrate is placed in contact with the portion of the flow that exhibits plug flow such that the portion of the flow exhibiting plug flow moves over the surface of the substrate. Additional methods and apparatuses for cleaning a substrate also are described. | 06-12-2014 |
20140332037 | Controls of Ambient Environment During Wafer Drying Using Proximity Head - A method for processing a substrate is provided which includes generating a fluid meniscus to process the substrate and applying the fluid meniscus to a surface of the substrate. The method further includes reducing evaporation of fluids from a surface in the substrate processing environment. | 11-13-2014 |
Jeffrey J. Farber, Delmar, NY US
Patent application number | Description | Published |
---|---|---|
20100294742 | Modifications to Surface Topography of Proximity Head - In an example embodiment, a wet system includes a proximity head and a holder for substrate (e.g., a semiconductor wafer). The proximity head is configured to cause a flow of an aqueous fluid in a meniscus across a surface of the proximity head. The surface of the proximity head interfaces with a surface of a substrate through the flow. The surface of the head is composed of a non-reactive material (e.g., thermoplastic) with modifications as to surface topography that confine, maintain, and/or facilitate the flow. The modifications as to surface topography might be inscribed on the surface with a conical scribe (e.g., with a diamond or SiC tip) or melt printed on the surface using a template. These modifications might produce hemi-wicking or superhydrophobicity. The holder exposes the surface of the substrate to the flow. | 11-25-2010 |
20110132400 | Method and System for Uniformly Applying a Multi-Phase Cleaning Solution to a Substrate - An apparatus used to supply a force onto a cleaning solution for processing a substrate for cleaning surface contaminants is disclosed. The apparatus includes a force applicator and a gate. The force applicator is configured to be adjusted to a first height to off the surface of the substrate. The gate is positioned adjacent to a trailing point of the force applicator and is configured to be adjusted to a second height off of the surface of the substrate to enable planarization of the cleaning solution as the solution moves to the trailing point. | 06-09-2011 |
20140014146 | Method and System for Uniformly Applying a Multi-Phase Cleaning Solution to a Substrate - A system for cleaning a substrate includes a carrier and a cleaning station. The carrier is capable of holding the substrate and is movably coupled to a pair of guide tracks extending a length of the system. The cleaning station includes a force applicator and a gate. The force applicator has an applicator length and is operatively coupled to the cleaning station. The force applicator is rotatable and is adjusted to a first height off the surface of the carrier as the substrate is being cleaned. The force applicator has a hollow structure with internal channels and openings dispersed throughout the applicator length to dispense cleaning solution to substrate surface. The gate is affixed to a trailing edge of the force applicator and is set to a second height off the surface of the carrier. The gate includes a gate length that at least spans the applicator length. | 01-16-2014 |
20140202503 | METHOD AND SYSTEM FOR UNIFORMLY APPLYING A MULTI-PHASE CLEANING SOLUTION TO A SUBSTRATE - A system for cleaning a substrate includes a carrier and a cleaning station. The carrier is capable of holding the substrate and is movably coupled to a pair of guide tracks extending a length of the system. The cleaning station includes a force applicator, a gate and a dispenser. The force applicator has an applicator length and is coupled to the cleaning station, is rotatable and is adjustable to a first height off the surface of the carrier during cleaning. The gate is a hollow structure disposed at a trailing edge of the force applicator. The gate is set to a height off the carrier surface that is less than or equal to the first height. The gate includes a gate length that at least spans the applicator length. The dispenser is disposed at a leading edge of the force applicator and is configured to supply cleaning solution during cleaning. | 07-24-2014 |
Jordan Ari Farber, Palatine, IL US
Patent application number | Description | Published |
---|---|---|
20120092125 | Method and Apparatus Pertaining to Message-Based Functionality - A movable barrier operator transmits a message to a remote peripheral platform and, upon determining that the remote peripheral platform is presently able to carry out a given functionality, responsively permits a particular function to be carried out by the movable barrier operator. Conversely, upon determining that it cannot be ascertained whether the remote peripheral platform is presently able to carry out the given functionality, the movable barrier operator responsively prevents the movable barrier operator from carrying out the particular function. Also, upon detecting that a targeted remote platform does not acknowledge a previously re-transmitted message and further upon detecting that this same remote platform has also not acknowledged a subsequent wirelessly-transmitted second message, the system can switch to automatically retransmitting that second message a lesser number of times than would otherwise be required. | 04-19-2012 |
Jordan Ari Farber, Naperville, IL US
Patent application number | Description | Published |
---|---|---|
20140282937 | Automated Credentialing of Device Newly Added to a Network - A device newly introduced to a network is automatically credentialed to be able to communicate over a network before the device first communicates with the network. For example, at a point of purchase, a user can provide network identification information to a merchant computing device that effects transfer of that information to the new device such that the new device can communicate directly with the network without initial credentialing directly between the unique device and the local network. In another example, the merchant computing device communicates with the local network to register a newly purchased device with the local network before the newly purchased device is introduced to the network. Accordingly, the network is configured to begin communications with the unique device without initial credentialing directly between the unique device and the local network. | 09-18-2014 |
Kenneth J. Farber, Granville, OH US
Patent application number | Description | Published |
---|---|---|
20140265403 | RAMP ASSEMBLY - A ramp assembly for installation on the rear of a transport vehicle. The ramp assembly is expandable from a stored position to an installed position. The ramp assembly includes an elongated base portion and an elongated connecting portion. A rail of one elongated side of the connecting portion is cooperatively shaped to engage at least one connector of an elongated side of the base portion. | 09-18-2014 |
Michael Farber, Pine Brook, NJ US
Patent application number | Description | Published |
---|---|---|
20140057873 | NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE - There is provided amino acid ester compounds comprising at least one nitric oxide releasing group, pharmaceutically acceptable salts thereof and compositions thereof. These compounds involve an amino acid side-chain or an amino acid derivative thereof and a nitric oxide releasing group as depicted in the following structures: | 02-27-2014 |
20140148438 | NITRIC OXIDE RELEASING AMINO ACID ESTER FOR TREATMENT OF PULMONARY HYPERTENSION AND OTHER RESPIRATORY CONDITIONS - There is provided compositions and methods for the treatment of respiratory conditions such as pulmonary hypertension and sickle-cell disease in a patient in need thereof. The composition and method are for treating a patient in need thereof by inhalation of a composition containing amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutical salts thereof. | 05-29-2014 |
20150093338 | NITRIC OXIDE RELEASING AMINO ACID ESTER FOR TREATMENT OF PULMONARY HYPERTENSION AND OTHER RESPIRATORY CONDITIONS - There is provided compositions and methods for the treatment of respiratory conditions such as pulmonary hypertension and sickle-cell disease in a patient in need thereof. The composition and method are for treating a patient in need thereof by inhalation of a composition containing amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutical salts thereof. | 04-02-2015 |
Michael Farber, Livingston, NJ US
Patent application number | Description | Published |
---|---|---|
20150202175 | Nitric Oxide Amino Acid Esters for Improving Vascular Circulation, and Prophylaxis or Treatment of a Condition Associated with Impaired Blood Circulation - The present document describes transdermal compositions comprising effective amounts of a nitric oxide amino acid ester compound, a skin penetration enhancer is association with a pharmaceutically acceptable carrier. Also described are methods of use for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation, including peripheral vascular diseases. | 07-23-2015 |
20150216799 | PREPARATION OF DESICCATED LIPOSOMES FOR USE IN COMPRESSIBLE DELIVERY SYSTEMS - The present document describes a compressible delivery formulation for transmucosal delivery of at least one compound which includes a micronized powder base; and a desiccated liposome formulation comprising at least one liposome containing at least one compound, process of making the same and process for making dosage forms from the formulation. | 08-06-2015 |
Michael Allen Farber, Moorestown, NJ US
Patent application number | Description | Published |
---|---|---|
20090030973 | Job Board/HRIS Integration and Selective Sharing of Interview Responses - A system and method to collect, transmit and access user information from an information collection system. User information is received with is submitted by a user in response to a posting of an opportunity made at a host web site. In response to receiving the user information, the user is transmitted a confirmation page comprising one or more tags. The one or more of the one or more tags are used in connection with enrolling the user with an information collection system by transmitting user identifier and user contact information to the information collection system. The enrolling step is accomplished without activity by the user. The one or more of the one or more tags are invisible or visible to the user. Data is collected from the user in response to one or more questions posed to the user. Access is provided to the user information and the user data to the sponsor through an access page. The access page includes a tag that visually indicates to the sponsor a status of data collection from the user. The sponsor activates the tag to thereby access the user data by the sponsor. | 01-29-2009 |
Neal M. Farber, Waban, MA US
Patent application number | Description | Published |
---|---|---|
20090123545 | Rapid Onset and Short Term Modafinil Compositions and Methods of Use Thereof - Compositions are described that comprise a modafÊnil component that is a combination of the d- and l-enantiomers of modafinil and wherein the modafÊnil component is greater than 50% by weight d-modafÊnil for use in promoting or enhancing the state of wakefulness, alertness, and/or central nervous system stimulation in an individual. | 05-14-2009 |
20110306669 | RAPID ONSET AND SHORT TERM MODAFINIL COMPOSITIONS AND METHODS OF USE THEREOF - Compositions are described that comprise a modafÊnil component that is a combination of the d- and l-enantiomers of modafinil and wherein the modafÊnil component is greater than 50% by weight d-modafÊnil for use in promoting or enhancing the state of wakefulness, alertness, and/or central nervous system stimulation in an individual. | 12-15-2011 |
Norm Farber, Freehold, NJ US
Patent application number | Description | Published |
---|---|---|
20100110909 | METHOD AND APPARATUS FOR ESTIMATING TRAFFIC FLOWS USING DYNAMIC LATENCY CONSTRAINTS - A method and apparatus that use dynamic latency to estimate traffic flows in a communication network are disclosed. For example, the method obtains a demand matrix having at least one point pair demand, and satisfies each of the at least one point pair demand in the demand matrix by selecting a shortest path that minimizes a dynamic latency and a number of hops. | 05-06-2010 |
Ron Farber, West Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20110256783 | Rotatable Electrical Connector - An electrical connector with a base and a lug rotationally coupled to the base with a bolt having an integral compression washer. The lug and the base have complementary gear faces. A set screw in the lug has a threaded shaft and a head with a projecting hexagonal configuration. The lug can be rotated so as to receive a relatively large gauge wire. | 10-20-2011 |
20120164894 | Rotatable Electrical Connector - An electrical connector with a base and a lug rotationally coupled to the base with a bolt having an integral compression washer. The lug and the base have complementary gear faces. A set screw in the lug has a threaded shaft and a head with a projecting hexagonal configuration. The lug can be rotated so as to receive a relatively large gauge wire. | 06-28-2012 |
Shlomo Michael Farber, Portland, OR US
Patent application number | Description | Published |
---|---|---|
20150143975 | Musical Notation Interface for the Visually Impaired - Various systems to aid a visually impaired musician to learn musical notation. The system includes a microprocessor with a memory adapted to store musical notation. Multiple transducers are operatively attached to the microprocessor. The transducers are spatially located on and/or in contact with a part of the body of the visually impaired musician. Responsive to the musical notation, the microprocessor is configured to signal the transducers to provide a physical or tactile sensation to the part of the body of the visually impaired musician. | 05-28-2015 |
Sonya Sophya Farber, New York, NY US
Patent application number | Description | Published |
---|---|---|
20120129152 | Diagnostic method for the prediction of the development of and control over the effectiveness of treatment of cardiovascular illnesses - A diagnostic method for the prediction of the development and control of the effectiveness of the treatment of cardiovascular diseases, in which patient tissue samples are taken, microassay are prepared, specific antiviral immunoglobulins are processed, the number of cells infected by two or more viruses before the beginning of treatment are determined, and the dynamic of the change in the number of infected cells and their interrelationships are established: when the number of cells infected by cytomegalovirus and any other viruses decreases by more than 50±10% in patients without symptoms of cardiovascular pathology, a diagnostic conclusion is high danger of the development of atherosclerosis; if the number of cells infected by cytomegalovirus and any other viruses exceeds 50±10% in patients with demonstrated clinical signs of cardiovascular system pathology, a diagnostic conclusion is drawn of the danger of the development of complications such as arrhythmia, thrombolytic embolism. | 05-24-2012 |
20120129153 | Diagnostic method for the prediction of the development and control of the effectiveness of the treatment of oncological illnesses - A diagnostic method, in which patient tissue samples are taken, microassay are prepared, specific anti-viral immunoglobulins are processed, the number of cells infected by two or more viruses before the beginning of treatment are determined, and the dynamic of the change in the number of infected cells and their interrelationships are established: if the number of blood cells infected by any two or more viruses exceeds 50±10% in patients without signs of oncological pathology, a diagnostic conclusion is drawn of a high danger of oncological illness in connection with immune system ineffectiveness; if the number of cells infected by any two or more viruses exceeds 50±10% in patients with diagnosed oncological illnesses, a diagnostic conclusion of the cancer tumor's low sensitivity to chemotherapy and the perspective of quick tumor metastasis is drawn. | 05-24-2012 |
20120129195 | Method of quick laboratory diagnosis if illnesses based on the discovery of specific proteins and equipment for its implementation - A method of quick laboratory diagnosis of diseases, based on the discovery of specific protein targets characteristic to the disease in the reaction of their specific interaction with other protein reagents, distinct in that specific protein targets for the given disease are hydrolyzed with proteolytic enzymes and then the chemical structure of the oligopeptide formula created is modified in such a way that its charge is changed to the opposite. This method of quick laboratory diagnosis of illnesses based on the discovery of specific proteins, and the equipment for its implementation, may be applied for the discovery of viral and microbial antigens in various human biological fluids. The method may also be used for the detection of new and little-studied infectious diseases in connection with the ease of diagnostic preparation. | 05-24-2012 |
20120129760 | Modified peptides with antiviral properties and methods for obtaining them - This invention may be used in human and veterinary medicine for the creation of a drug that is effective perorally in the treatment of many viral infections, such as influenza, herpes, and cytomegalovirus. | 05-24-2012 |
20120129787 | Modified oligopeptides with anticancer properties and methods of obtaining them - This invention may be used in human and veterinary medicine for the creation of a drug that is effective perorally in the treatment of oncological illnesses. | 05-24-2012 |
20120130060 | Modified antisense oligopeptides with anticancer properties and method of obtaining them - This invention may be used in human and veterinary medicine for the creation of a drug that is effective in the treatment of oncological illnesses in animals and humans. | 05-24-2012 |
20120130699 | Method of molecular design and synthesis of therapeutic and preventive drugs - Industrial Application: This invention may be used in human and veterinary medicine for the design (creation and synthesis) of therapeutic and preventive drugs that are effective for the treatment of oncological and viral human and animal illnesses and for the design of new medicines. | 05-24-2012 |
20120195856 | Method of treating patients with cardiovascular illness - This invention may be used in human and veterinary medicine in combination with traditional methods of treatment of cardiovascular illnesses for the purpose of increasing their effectiveness. | 08-02-2012 |
20120195911 | Method of treatment of cancer patients - This invention may be used in human and veterinary medicine in combination with traditional methods of treatment of oncological illnesses for the purpose of increasing their effectiveness. | 08-02-2012 |
20120195925 | Vaccines with increased immunogenicity and methods for obtaining them - Vaccines with increased immunogenicity, distinct in that in the capacity of a specific immunogenic component, whole vaccine antigens or vaccine antigens that have been cut into oligomer fragments are used; the mixture (assembly) of oligomer fragments or whole antigen obtained is modified by changing its molecular charge to the opposite. | 08-02-2012 |
20120195945 | Cosmetological and pharmaceutical formulae for the rejuvenation and restoration of skin, including after surgical procedures - This invention is related to pharmacology and cosmetology and may be used in the capacity of a medicinal and cosmetic substance for skin anti-aging, scar reduction, treatment of post-operative peritoneal commissures, increasing the speed of post-operative tissue regeneration, and for the liquidation of cellulite. | 08-02-2012 |
20120196801 | Wound-healing, anti-ambustial, regenerating, and anti-viral pharmaceutical formula for local administration - The main active ingredients of the formula are papaverin, bendazol, and insulin. The drug may be produced in soft, liquid medicinal form or as an aerosol. | 08-02-2012 |
20120197003 | Modified oligopeptides for the treatment of pancreatitis, stomach ulcers, and other hyperenzymemias based on enzyme peptide inhibitors and methods for obtaining them - Modified oligopeptides for the treatment of pancreatitis, stomach ulcers, and other hyperenzymemias based on an enzyme peptide inhibitor where in the capacity of the main active ingredient, a mixture (assembly) of chemically modified oligopeptides are used that are products of autological hydrolysis of the same proteolytic enzymes of trypsin, chymotrypsin, and papain, with changes of their molecular charges to the opposite through acylation with succinic anhydride and alkylation by monochloracetic acid. | 08-02-2012 |
20130288230 | Method for identification of a natural biopolymer - The invention presents a method of identifying natural biopolymer—a protein, DNA, RNA in biological fluids and environmental objects, which is based only on the structure of the biopolymer and does not require pathogen genome sequencing, or animals vaccination by biopolymer-antigen. For this purpose the biopolymer itself is taken—a protein, DNA, or RNA, that is fragmented with enzyme to oligomer fragments—a mixture of oligopeptides, oligonucleotides DNA mixture, mixture of RNA oligonucleotides, without dividing the mixture into individual components, then carboxylation of structure in oligomer components is performed by acylation or alkylation. | 10-31-2013 |
20140220556 | Method of Design and Synthesis of a New Drug - A method of design and synthesis of a new drug. This invention may be used in human and veterinary medicine for the design of new drugs that are effective in the treatment of oncological and viral human and animal illnesses and for the design of new medicines. In the method a biopolymer target for the drug action is selected; then the quantity of nitrogen-containing positively charged groups available for modification is calculated. Biopolymer target may be cut into oligomer fragments. Some of calculated nitrogen-containing positively charged groups are substituted with negatively charged groups by combinatorial modification. The obtained supramolecular assemblies are used as drug for the biopolymer target. | 08-07-2014 |
20140309276 | Pharmaceutical Composition Comprising a Mixture of Carboxylated Oligonucleotides - The invention describes a pharmaceutical composition, comprising a mixture of carboxylated oligonucleotides, obtained by hydrolysis of natural polynucleotides, that results in oligonucleotide mixture, and carboxylation of purine nucleotide bases in the oligonucleotide mixture. The oligonucleotide mixture (DNA, RNA, or a combination of the two) of plant, animal, or fungal origin is conducted through chemical or biochemical enzymatic procedures, and then, a chemical modification of the oligonucleotides is provided, with carboxylation of their purine nucleotide bases through alkylation with monochloroacetic acid, or acylation with succinic anhydride. The pharmaceutical composition may be used in humans and animals for cancer treatment, immunodeficiency, viral infection diseases, etc. | 10-16-2014 |
20150072929 | Pharmaceutical composition comprising a mixture of carboxylated oligopeptides - A pharmaceutical composition comprising a mixture of carboxylated oligopeptides, derived by hydrolysis of eukaryotic or prokaryotic cells and their subsequent partial carboxylation through acylation or alkylation of the amino acid and basic amino acid residues in the amino terminal structure of the oligopeptides. The resulting pharmaceutical composition can be used in production of medical drugs effective in the treatment of cancer, pancreatitis, viral infection, for the development of vaccines. | 03-12-2015 |
20150174208 | Cosmetic and pharmaceutical composition with modified olygopeptides in form of supramolecular assembly - The invention is a cosmetic and pharmaceutical liposomal composition which comprises a mixture of carboxylated oligopeptides derived from natural polypeptides; insulin; hyaluronidase and collagenase by their enzymatic hydrolysis; followed by a carboxylation of the free amino groups of lysine, histidine, and additional hydrolysis of terminal amino groups in the oligopeptides. Natural polypeptides may be hydrolyzed with a proteolytic enzyme to form a mixture of oligopeptides and succinylated them. Next, the resulting mixture was injected into the liposomes by classical methods to improve the intestinal absorption and bioavailability in the body, prolonging the action of the system. Such a system behaves as quasi-live and is capable of forming supramolecular complexes with the original proteins, such as insulin and acylated insulin oligopeptides, or insulin receptors on a cell and acylated insulin's oligopeptides. These cosmetic formulations may be used as prophylactic and therapeutic drugs in the prevention of infectious diseases as do vaccines in the treatment of cancer; pancreatitis and other diseases; rejuvenation of skin and body; and acceleration of wound healing. | 06-25-2015 |
Steven Farber, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20090136428 | High Throughput Genetic Screening Of Lipid And Cholesterol Processing Using Fluorescent Compounds - The present invention utilizes fluorescent lipids, particularly quenched phospholipid or cholesterol analogues, to facilitate screening for phenotypes representing perturbations of lipid and/or cholesterol processing in a vertebrate; screening for genetic mutations that lead to disorders of phospholipid and/or cholesterol metabolism; and screening of compounds designed to treat disorders of phospholipid and/or cholesterol metabolism in the vertebrate. | 05-28-2009 |
Stuart H. Farber, Horsham, PA US
Patent application number | Description | Published |
---|---|---|
20140181185 | Systems and Methods For Providing Customized Media Channels - The present application describes systems and methods for creating customized media channels. A method of the invention according to some embodiments includes: (a) transmitting to a user device information comprising a list of music genres; receiving from the user device a message indicating that a user selected one of the listed genres and including an identifier identifying the selected genre; selecting one or more media content items in response to receiving the message, wherein the selection is based, at least in part, on (i) the genre selected by the user and (ii) profile information associated with a user identifier input by the user and/or a device identifier associated with the device; and transmitting the selected media content items to the device. | 06-26-2014 |